Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Michael Bierer, MD
Contributor
Since getting his MD at Albert Einstein College of Medicine, Michael Bierer has been at Massachusetts General Hospital in Boston for over 30 years. Along the way he got an MPH in Health Policy and Management at the Harvard School of Public Health and a participated in a Fellowship in Addiction Medicine at the Boston University School of Medicine and the Boston VA.
Dr. Bierer is currently a physician on staff in Internal Medicine at MGH and an Assistant Professor of Medicine at Harvard Medical School. He has busy primary care and addictions practices. Dr. Bierer has been teaching staff and residents about the management of addictions for many years. He is currently part of the new hospital-wide effort to address substance use disorders in a comprehensive and innovative, multidisciplinary program. He is also one of the “voices” of the New England Journal of Medicine.”
Posts by Michael Bierer, MD
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
